1.
Nessel TA, Morris JB, Roshak T, Sofen BD. Rapid development of multiple nonmelanoma skin cancers secondary to ruxolitinib: a case report. Int J Res Dermatol [Internet]. 2021 Jun. 24 [cited 2025 Mar. 21];7(4):572-4. Available from: https://www.ijord.com/index.php/ijord/article/view/1318